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Wnt/β-cateninOxysterols, oxidized derivatives of cholesterol, are biologically active molecules. Speciﬁc oxysterols have potent
osteogenic properties that act on osteoprogenitor cells. However, the molecular mechanisms underlying these
osteoinductive effects on embryonic stem cells (ESCs) are unknown. This study investigated the effect of an
oxysterol combination of 22(S)-hydroxycholesterol and 20(S)-hydroxycholesterol (SS) on osteogenic differenti-
ation of ESCs and the alterations to mitochondrial activity during differentiation. Osteogenic differentiation was
assessed by alkaline phosphatase (ALP) activity, matrix mineralization, mRNA expression of osteogenic factors,
runt-related transcription factor 2, osterix, and osteocalcin, and protein levels of collagen type IA (COLIA) and
osteopontin (OPN). Treatment of cells with SS increased osteoinductive activity compared to the control
group. Intracellular reactive oxygen species production, intracellular ATP content, mitochondrial membrane
potential, mitochondrial mass, mitochondrial DNA copy number, and mRNA expression of peroxisome
proliferator-activated receptor-γ coactivators 1α and β, transcription factors involved in mitochondrial biogen-
esis, were signiﬁcantly increased during osteogenesis, indicating upregulation of mitochondrial activity.
Oxysterol combinations also increased protein levels of mitochondrial respiratory complexes I–V. We also
found that SS treatment increased hedgehog signaling target genes, Smo and Gli1 expression. Inhibition of Hh
signaling by cyclopamine suppressed mitochondrial biogenesis and ESC osteogenesis. Subsequently, oxysterol-
induced Wnt/β-catenin pathways were inhibited by repression of Hh signaling and mitochondrial biogenesis.
Transfection of β-catenin speciﬁc siRNA decreased the protein levels of COLIA and OPN, as well as ALP activity.
Collectively, these data suggest that lipid-based oxysterols enhance differentiation of ESCs toward the osteogenic
lineage by regulating mitochondrial activity, canonical Hh/Gli, and Wnt/β-catenin signaling.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Embryonic stem cells (ESCs) are characterized by two essential
functions, unlimited proliferation and differentiation into speciﬁc line-
ages [1]. These properties make them valuable for cell therapy
applications and tissue engineering. ESCs are particularly good candi-
dates for regenerative medicine research aimed at repairing bone
defects with low numbers of osteoprogenitor cells because they are
capable of differentiating along the osteoblastic lineage [2]. For these
applications, differentiation should occur in well-deﬁned conditions
with speciﬁc stimulatory culture medium supplements. However, very
few molecules have been reported as being osteoinductive [3]. Thus, a
number of groups have focused on establishing differentiation protocols
using novel factors and strategies, which improve the differentiation of
ESCs into osteoblastic cells, particularly for applications requiring mass
production [4,5].
Oxysterols are oxidized derivatives of cholesterol, which are impor-
tant in many biological processes including cholesterol homeostasis,inﬂammation, apoptosis, and cellular differentiation [6–9]. Recently,
oxysterol combinations, 22(R)- or 22(S)- and20(S)-hydroxycholesterol,
were reported to possess potent osteogenic activity [10]. These
oxysterol combinations enhanced in vitro osteogenic differentiation
and in vivo bone formation by activating speciﬁc signaling molecules
[11,12]. However, the molecular details of this activity and many
other osteogenic processes are not well understood. In particular,
little attention has been paid to the effect of oxysterols on mitochon-
drial activation and biogenesis during ESC differentiation.
Mitochondria, the powerhouse of cells, play an important role in the
metabolism of nutrients. They can vary in number and function in
different cell types in response to altering energy demands [13].
Mitochondrial biogenesis and oxidative phosphorylation, as well as
replication of mitochondrial DNA, are key regulatory events in cell
proliferation, differentiation, and death [14,15]. These mitochondrial
functions are signiﬁcantly involved in early embryonic development
[16]. Recently, researchers reported that stem cells utilize speciﬁc
metabolic pathways and that mitochondrial function is involved in
regulation of stem cell maintenance and differentiation [17,18]. In fact,
differentiating stem cells show increases in mitochondrial mass
and oxygen consumption, which contributes to spontaneous ESC
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Fig. 2. Oxysterols affect intracellular ROS, ATP levels, andmitochondrial membrane potential during osteogenic induction. (A) Cells were incubated with SS at different concentrations for
2 h and then 10 μM CM-H2DCF-DA was added. After 40 min, DCF ﬂuorescence was determined by spectroﬂuorophotometer. (B) Cellular ATP concentration, (C) relative membrane
potential, and (D) mitochondrial morphology were assessed as described in the Materials and methods. The treatment of CCCP was used as a positive control. Values are reported as
mean ± S.D. of four independent experiments, *P b 0.05 vs. the control value.
563I.K. Kwon et al. / Biochimica et Biophysica Acta 1853 (2015) 561–572differentiation [19]. Moreover, upregulation of mitochondrial
biogenesis has been shown to be involved in mesenchymal stem cell
differentiation in response to osteoinductive signals [20]. While
mitochondrial function and biogenesis are important in stem cell ho-
meostasis, little is known about the biological signiﬁcance of these
factors and about the molecular mechanisms responsible for regulating
stem cell fate.
Emerging evidences indicate the important role of hedgehog (Hh)
signaling in bone homeostasis by regulating bone formation and
resorption as well as in bone repair by modulating of cell behaviors
[21,22]. Hh signaling is activated by receptors including the G protein-
coupled receptor smoothened (Smo) and the twelve-pass membraneFig. 1. Oxysterols affect ESC osteogenesis. Cells were incubated in osteogenic medium at differ
(B) Alizarin Red quantiﬁcationwere assessed as described in theMaterials andmethods. (C) Th
Moreover, (D) the protein levels of COLIA and OPN were determined byWestern blot analysis
condition determined from densitometry relative to β-actin, ⁎P b 0.05 vs. the control value. The
independent experiments, *P b 0.05; **P b 0.01; or #P b 0.001 vs. the control value at each dayprotein patched (PTCH). The receptor PTCH represses Smo activation
in the absence of Hh stimulation, but this inhibition is released when
Hh is introduced. Eventually, the end point of Hh signaling, the Gli
(glioma-associated oncogene family members) transcription factor
modulates Hh signaling transduction referred to as canonical Hh/Gli
pathway [23]. Oxysterols were recently implicated as crucial activators
of Hh signaling in pluripotent mesenchymal cells [12]. However,
whether Hh signaling controls osteogenic speciﬁcation of ESCs, and
this mechanism arises from oxysterols, remain unclear. Thus, it is
important to determine how Hh signaling pathway can regulate
processes that lie on either oxysterol-induced intracellular signaling or
the osteogenic spectrum of ESCs.ent oxysterol combinations (SS; 0.1, 1, 5, 10 μM) for 4, 7, or 14 days. (A) ALP activity and
emRNA levels of Runx2, OSX, and OCNwere analyzed after 7 days of osteogenic induction.
or (E) immunostaining. Panels (bars) denote the mean ± S.D. of ﬁve experiments for each
nuclei were stained with DAPI, shown in blue. Values are reported asmeans± S.D. of ﬁve
.
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Fig. 3. Oxysterols affect mitochondrial biogenesis and respiratory enzyme complexes. Cells were cultured in the absence or presence of 1 μM SS for 4, 7, and 14 days. Next,
(A) mitochondrial mass, (B) mRNA expression levels of PGC-1α and PGC-1β, (C) mtDNA copy number were measured as described in the Materials and methods. (D) The protein levels
ofmitochondrial respiratory enzyme complexes after 4 days of osteogenic inductionwere detected byWestern blot analysis. All datawere obtained from three independent experiments,
*P b 0.05 vs. the control value.
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multiple biological events such as morphogenesis, cell fate determina-
tion, and differentiation during embryonic development [24,25]. Wnt
signaling is divided into the canonical and the non-canonical pathways,
depending on the β-catenin, which act as a coactivator of the T-cell
factor (TCF)/lymphoid enhancer factor (LEF) transcription factors,
resulting in cellular responses via the increased expression of target
genes [26]. It is well known that canonical Wnt/β-catenin signaling is
considered as a key regulator of bone biology [27,28]. Increasing
evidences suggest that activation of β-catenin through Wnt signaling
enhances differentiation of stem/progenitor cells into osteogenic line-
age and subsequent plays an important role in bone formation and
regeneration [29–31]. Thus, exploring the mechanism of Wnt pathway
and its related signaling pathways can suggest a practical strategy for
controlling ESCs during osteogenic differentiation.
In the present study, we demonstrate the importance of mitochon-
drial function during ESC osteogenic differentiation in response to
oxysterols. We also provide evidence for the presence of mitochondria-
coordinated Hh/Gli and Wnt/β-catenin signaling pathways, which
provides new potential cell therapy approaches for oxysterol-induced
bone regeneration.Fig. 4.CCCP and AZT affectmitochondrial activity and oxysterol-induced osteogenic differentiat
Next, (A) ATP content, (B)membrane potential, (C) ALP activity, (D)mRNA levels of Runx2, OSX
the Materials and methods. (F) Cells were pretreated with 10 μM of AZT before SS treatment
independent experiments, ⁎P b 0.05 vs. the control value or #P b 0.05 vs. the SS treatment alon2. Materials and methods
2.1. Materials
The mouse ESC line D3 was obtained from the American Type
Culture Collection (Rockville, MD, USA). Fetal bovine serum (FBS) was
purchased from Gibco-BRL (Gaithersburg, MD, USA). Unless otherwise
speciﬁed, chemicals and laboratory wares were purchased from
Sigma Chemical Co. (St. Louis, MO, USA) and Falcon Labware (Becton-
Dickinson, Franklin Lakes, NJ, USA).
2.2. ES cell culture and embryoid body formation
The ESCs were prepared as previously described [32]. Cells were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM) (Gibco-BRL)
supplemented with 1.7 mM L-glutamine, 0.1 mM β-mercaptoethanol,
5 ng/mL mouse leukemia inhibitory factor (LIF), 15% FBS, and 1%
penicillin and streptomycin, without a feeder layer at 37 °C in an atmo-
sphere containing 5% CO2. To form embryoid bodies (EBs), the cells
were dissociated by 0.05% trypsin/EDTA. Then 2000 cells were hung
from the lids of 100-mm culture dishes for two days in 20 μL DMEMion of ESCs. Cells were pretreatedwith 2 or 5 μMof CCCP for 2 h prior to addition of 1 μMSS.
, and OCN, aswell as (E) the protein levels of COLIA andOPNwere analyzed as described in
, and ALP activity and [Ca2+]i were assessed. Values are reported as mean ± S.D. of four
e.
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days. Thus, EBs of the same culture age (5 days old) were used in each
experiment.
2.3. Osteogenic differentiation of ESCs
ESC differentiation was performed as previously reported [33]. EBs
were plated onto gelatin-coated six-well plates or 60-mm dishes
(10–15 EBs per well) and maintained in an osteogenic medium
consisting of a α minimal essential medium (α-MEM) containing 5%
FBS, 50 μg/mL ascorbic acid, 1 μM dexamethasone, and 3 mM β-
glycerophosphate for 1 day before the application of oxysterols (SS). To
promote osteogenic differentiation, oxysterols at different concentrations
(0.1 to 10 μM) were added to the osteogenic medium, which was
changed every other day. Oxysterol was dissolved in dimethyl sulfoxide
(DMSO) immediately before use, and the ﬁnal concentration of DMSO
did not exceed 0.1% (v/v) in any of the experiments. DMSO was used as
a control; its concentration was always 0.1%.
2.4. Alkaline phosphatase activity
Cells were lysed using a 50 mM Tris–HCl buffer (pH 7.0) containing
1% (v/v) Triton X-100 and 1 mM PMSF and the total protein was
quantiﬁed by the Bradford procedure [34]. ALP activity was analyzed
with the total cell lysate by adding 200 μL of p-nitrophenylphosphate
(pNPP) as a substrate (Sigma, USA) for 30 min at 37 °C. The reaction
was paused by adding 3 N NaOH and the absorbance was read with
spectrophotometer at 405 nm. The enzyme activity was validated as
mM/100 μg of protein.
2.5. Alizarin Red staining
The cells were ﬁxed for 30 min in 4% paraformaldehyde ﬂuid,
washed three times with ice-cold phosphate-buffered saline (PBS),
stained for 5 min with Alizarin Red (Sigma, USA). To quantify
mineralization, bound dye was solubilized in 10mM sodium phosphate
containing 10% cetylpyridinium chloride and quantiﬁed spectrophoto-
metrically at 562 nm.
2.6. Intracellular calcium assay
Cells were washed three times with PBS and lysed in 50 mM Tris–
HCl buffer (pH 7.0) containing 1% (v/v) Triton X-100 and 1 mM PMSF
without EDTA after they were incubated with oxysterol combination
for 14 days. The protein content was then quantiﬁed according to the
method by Bradford [34]. The intracellular calcium content was
measured using a calcium assay kit according to the manufacturer's
instructions (BioAssay Systems, Hayward, CA, USA.), and the absor-
bance was read spectrophotometrically at 602 nm. The calcium content
level was expressed as mg/mg protein.
2.7. RNA isolation and Real Time RT-PCR
The RNA extraction was prepared using TRIzol reagent (Invitrogen,
Carlsbad, CA), following the manufacturer's instructions. The real-time
RT-PCR was then performed in the Rotor-Gene 2000 real-time thermal
cycling system (Corbett Research, NSW, Australia) using a QuantiTect
SYBR Green RT-PCR kit (QIAGEN, CA, USA). The primers used were 5′-
CCAACTTCCTGTGCTCCGTG-3′ (sense), 5′-TCTTGCCTCGTCCGCTCC-3′
(antisense) for Runx2, 5′-ACCAGGTCCAGGCAACAC-3′ (sense), 5′-Fig. 5. Canonical Hh signaling was evaluated during oxysterol-induced ESC osteogenic differen
7 days and then the mRNA expression of Smo and Gli1 was analyzed. Cells were pretreated
mass, mtDNA copy number, (C) ATP content, and the protein levels of respiratory complexes
methods. A representative result from ﬁve independent experiments is shown, ⁎P b 0.05 vs. thGGGCAGTCGCAGGTAGAA-3′ (antisense) for OSX, and 5′-CAGGAGGG
CAATAAGGTAGT-3′ (sense), 5′-GAGGACAGGGAGGATCAAG-3′ (anti-
sense) for OCN, 5′-AAAGGGCCAAGCAGAGAGA-3′ (sense), 5′-GTAAAT
CACACGGCGCTCTT-3′ (antisense) for PGC-1α, 5′-CTCCAGGCAGGTTC
AACCC-3′ (sense), 5′-GGGCCAGAAGTTCCCTTAGG-3′ (antisense) for
PGC-1β. The temperature of the PCR products was increased from 65
to 99 °C at a rate of 1 °C/5 s, and the resulting data was analyzed using
the software provided by the manufacturer.
2.8. Western blot analysis
The extracted protein (20 μg) was separated by 10% SDS-PAGE and
blotted onto polyvinylidene diﬂuoride (PVDF) membranes. The mem-
branes were washed with TBST [10 mM Tris–HCl (pH 7.6), 150 mM
NaCl, 0.05% Tween-20], blocked with 5% skimmilk for 1 h, and incubat-
ed with the appropriate primary antibodies [anti-collagen type I, anti-
osteopontin, anti-β-actin (Santa Cruz Biotechnology, CA, USA), and
anti-Oxphos complex kit (Invitrogen, CA, USA)] at the dilutions recom-
mended by the supplier. The membrane was then washed, and the
primary antibodies were detected with goat anti-rabbit IgG or goat
anti-mouse IgG conjugated to horseradish peroxidase. The blots were
developed with enhanced chemiluminescence (ECL) (Santa Cruz
Biotechnology) and exposed to X-ray ﬁlm (Eastman-Kodak, Rochester,
NY, USA).
2.9. Immunoﬂuorescence staining
The cells were ﬁxed and incubated with mouse anti-collagen type I
or anti-osteopontin antibody (1:100, Santa Cruz Biotechnology,
Delaware, CA) for 2 h at room temperature. Subsequently, the
ﬂuorescein isothiocyanate-conjugated (FITC-conjugated) anti-mouse
IgG (1:100) was treated for 2 h at room temperature. Fluorescence im-
ages were obtained using a ﬂuorescence microscope (Fluoview 300,
Olympus).
2.10. Measurement of intracellular ROS
Cellular levels of ROS were measured using 5-(and-6)-chloromethyl-
2′,7′-dichlorodihydro-ﬂuorescein diacetate (CM-H2DCF-DA; Molec-
ular Probes, Eugene, OR, USA) according to the method described
by Ali et al. [35]. EBs were incubated with oxysterols (SS) at different
concentrations for 2 h and 10 μMCM-H2DCF-DAwas added. After 40min,
DCF ﬂuorescence was determined by spectroﬂuorophotometer (RF-
5301PC, Shimadzu, Japan) at an excitation wavelength of 488 nm and
an emission wavelength of 530 nm.
2.11. Measurement of ATP concentration
Cellular ATP concentration was determined in ESC-derived
osteoblasts on fourth day of differentiation using the ATP Assay kit
(BioVision, Mountain View, CA, USA), following the manufacturer's
instructions. The ATP concentrations were measured by colorimetric
(OD = 570 nm) method.
2.12. Fluorescent microscopic detection of mitochondrial membrane
potential
The membrane-permeant red ﬂuorescent dye tetramethylrhodamine
methyl ester (TMRM, Life Technologies)was used to assess themitochon-
drial membrane potential in ESC-derived osteoblasts according to atiation. (A) Cells were treated with different oxysterol combinations (0.1, 1, 5, 10 μM) for
with 5 μM of cyclopamine for 2 h prior to addition of 1 μM SS. Next, (B) mitochondrial
, as well as (D) ALP activity and [Ca2+]i were analyzed as described in the Materials and
e control value or #P b 0.05 vs. the SS treatment alone.
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568 I.K. Kwon et al. / Biochimica et Biophysica Acta 1853 (2015) 561–572previously describedmethod [36]. The 4 day-differentiated cells were in-
cubated in media containing a 100 nM ﬁnal concentration of TMRM for
30 min in a 37 °C, 5% CO2 incubator. The cells were washed with PBS
and ﬁxed with 4% paraformaldehyde for 10 min. After another wash
with PBS, cells were placed onto slides using mounting medium contain-
ing DAPI. Fluorescence imageswere obtained using a ﬂuorescencemicro-
scope (Fluoview 300, Olympus). For quantitative assessment of
membrane potential, the ﬂuorescence intensity was measured by
spectroﬂuorophotometer (RF-5301PC, Shimadzu, Japan) at ex/em 549
nm/573 nm.2.13. Determination of mitochondrial mass
The ﬂuorescent dye NAO (Invitrogen, CA, USA) was used tomeasure
mitochondrial mass. Cells were trypsinized and resuspended in PBS
containing 10mMNAO. After incubation for 30min at room temperature,
the ﬂuorescence intensity was measured by spectroﬂuorophotometer
(RF-5301PC, Shimadzu, Japan) at ex/em 485 nm/535 nm.2.14. Determination of mtDNA copy number
Total DNA was extracted from cells using the QIAamp DNA Mini Kit
(Qiagen Technologies, USA) according to the instructions of the
manufacturer. The mtDNA copy number was determined using a real-
time quantitative PCR method. The primers for mtDNA were 5′-CCCA
GCTACTACCATCATTCAAGT-3′ (sense), 5′-GATGGTTTGGGAGATTGGTT
GATGT-3′ (antisense). The PCR products were detected by SYBR Green
reagent. ThemtDNA copy numberwas obtained using theΔΔCt method
where all samples are ﬁrst normalized to the level of β-actin then
relative normalized values were compared between the control and
treatment groups.2.15. TCF/LEF luciferase reporter assay
Cells were transfected with Top-Flash or Fop-Flash plasmids (as a
negative control) using Lipofectamine 2000 (Invitrogen) according to
the manufacturer's instructions. After 6 h, cells were incubated
with FBS containing medium supplemented with SS or SS plus
AZT. Luciferase activity was measured using the Luciferase Assay
System (Promega, Madison, WI) according to the manufacturer's
protocol.2.16. siRNA transfection
The transfection of siRNAwas performed according to the previously
described method [37]. Small interference RNA (siRNA) targeting Gli1
or β-catenin was produced using a commercial kit that contains three
target sequences to Gli1 orβ-catenin (IDT, IntegratedDNA Technologies
Inc., Coralville, IA, USA). The siRNA that inhibited Gli1 or β-catenin
expression the most as determined by western blotting analysis was
used in further experiments. Brieﬂy, cells were transfected for 24 h
with either siRNA speciﬁc to Gli1, β-catenin (20 nM) or negative control
siRNA (scrambled), using TransIT-TKO transfection reagents (Mirus,
Madison, WI, USA) according to the manufacturer's instructions, before
being subjected to the various treatments.2.17. Statistical analysis
All data are expressed as mean ± standard deviation (S.D.). One-
way ANOVA was used for multiple comparisons (Duncan's multiple
range test), using SPSS software ver. 10.0. A P value b 0.05 was
considered signiﬁcant.3. Results
3.1. Induction of ESC osteogenic differentiation by oxysterols
To examine the osteogenic effect of oxysterols on ESCs, cells were
exposed to 0.1–10 μΜ of oxysterol cocktail, 20(S)-hydroxycholesterol
(20S) + 22(S)-hydroxycholesterol (22S) (SS, 1:1) for 4, 7, and
14 days. ALP activity and mineralization were then determined.
Fig. 1A and B show that ALP activity and mineralization were signiﬁ-
cantly enhanced in ESCs exposed to 0.1, 1, and 5 μΜ of SS. To further
characterize osteoblastic differentiation, we assessed mRNA expression
of osteogenic target genes Runx2, OSX, andOCNusing real time RT-PCR.
Although the genes did not increase in a dose-dependent manner,
cultures treated with SS demonstrated higher gene expression com-
pared to the control groups (Fig. 1C). Particularly, a maximal increase
in the level of each gene was observed with 1 μM SS. Slightly decreased
levels were observed with higher than 5 μM treatment. We also
analyzed the oxysterol effect on ESC osteogenic differentiation by deter-
mining the protein levels of osteogenicmarkers, COLIA andOPN at day 7
of osteogenic induction. Western blot analyses showed that the level of
each protein dose-dependently increased in cells incubated with SS at a
range from 0.1 to 5 μM; these levels decreased in cultures at 10 μM SS
(Fig. 1D). Moreover, immunoﬂuorescence staining with COLIA and
OPN conﬁrmed that the treatment of SS enhances ESC osteogenic
differentiation (Fig. 1E).
3.2. Increased mitochondrial activity during oxysterol-induced osteogenic
differentiation
To investigate oxysterol stimulation of mitochondrial activity during
ESC differentiation, we ﬁrst analyzed intracellular ROS production,
intracellular ATP content, and mitochondrial membrane potential after
4 days of osteogenic induction. Intracellular ROS levels, ATP content,
and mitochondrial membrane potential of cells incubated with SS
signiﬁcantly increased compared to untreated cells (Fig. 2A–C). Particu-
larly, a maximal increase in mitochondrial content was observed with a
stimulation of 1 μM SS (1.61-fold increase in ROS level; 1.56-fold
increase in ATP content; and 2.7-fold increase in membrane potential;
⁎P b 0.05). Images of cells stained with TMRM were recorded by
confocal microscopy (Fig. 2D). Fluorescence was much stronger in
cells treated with SS than in the control group, whereas cells treated
with 5 μM of mitochondrial uncoupler CCCP, reﬂected a decrease in
TMRM ﬂuorescence intensity compared with untreated cells. The
applied concentration of CCCP was selected not to affect cellular
function but to inhibit mitochondrial activity (Supplemental Data 1).
3.3. Effect of oxysterols on mitochondrial biogenesis and expression of
respiratory enzymes during osteogenic induction
To determine mitochondrial mass after SS treatment, we used the
ﬂuorescent dye 10-n-nonyl-acridine orange (NAO). The relative NAO
intensity of the SS-treated cells was signiﬁcantly higher than that of
the control after 4 days of osteogenic induction (⁎P b 0.05; Fig. 3A).
We examined mRNA expression levels of PGC-1α and PGC-1β, which
are mitochondrial biogenesis-associated genes. Using real-time RT-
PCR analysis, we observed a gradual increase in PGC-1α and PGC-1β
expression concomitant with osteogenic differentiation of ESCs
(Fig. 3B). Mitochondrial DNA (mtDNA) copy number analyzed by real-
time PCR increased in a time-dependent manner (⁎P b 0.05) by
treatment with 1 μM SS (Fig. 3C). To further examine the enhancement
of mitochondrial respiratory function during oxysterol-induced osteo-
genic differentiation,we assessed the expression levels ofmitochondrial
complex proteins by Western blot after 4 days of osteogenic induction.
As shown in Fig. 3D, we found a signiﬁcant increase in the protein level
of each complex at 0.1, 1, and 5 μM of SS treatment. However, we also
found a slight decrease in complex protein levels at 10 μM SS. These
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activity is essential for oxysterol-induced osteogenic differentiation of
ESCs.
3.4. Mitochondrial contribution to oxysterol-induced osteogenic
differentiation
We further conﬁrmed that the observed increased mitochondrial
activity can contribute to osteogenic differentiation of ESCs using the
mitochondrial uncoupler CCCP and mitochondrial biogenesis inhibitor
Zidovudine (AZT). First, we evaluated the effect of CCCP on intracellular
ATP content and mitochondrial membrane potential of the oxysterol-
treated cell population. When cells were pretreated with 2 or 5 μM ofC
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of cells with CCCP inhibited oxysterol-induced ALP activity. Similarly,
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of COLIA and OPN were examined. We found that oxysterol-induced
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CCCP after 7 days of osteogenic induction (Fig. 4D and E). When cells
were treated with 10 μM of AZT, intracellular ATP levels, membrane
potential, NAO, and mtDNA copy number were signiﬁcantly decreased
(Supplemental Data 2). Ultimately, the association of mitochondrial
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tion ([Ca2+]i) by oxysterols were prominently attenuated by inhibition
of mitochondrial biogenesis with AZT treatment. These results suggest
that mitochondrial activity and biogenesis are essential for oxysterol-
mediated ESC osteogenic differentiation.
3.5. Activation of hedgehog signaling during oxysterol-mediated osteogenic
differentiation
Given the role of Hh signaling in osteogenic development of plurip-
otent stem cells [12], we next considered whether Hh signaling is
speciﬁcally associated with mitochondrial activity and osteogenic
differentiation in ESCs. As shown in Fig. 5A, cells treatedwith SS demon-
strated higher Smo and Gli1 gene expression compared to the control
groups. When cells were pretreated with Smo inhibitor, cyclopamine,
oxysterol-induced increases in mitochondrial mass, mtDNA copy
number, ATP levels, and respiratory complex protein expression were
signiﬁcantly attenuated (Fig. 5B, C). Moreover, this Smo inhibition
suppressed the increase of ALP activity and [Ca2+]i by oxysterols
(Fig. 5D). These results indicate that the canonical Hh/Gli1 pathway
plays an important role in oxysterol-mediated ESC osteogenesis
through positively regulating mitochondrial biogenesis and respiratory
function.
3.6. Effects of hedgehog pathway and mitochondrial biogenesis on
canonical Wnt signaling
Based on the validated roles ofWnt/β-catenin signaling in osteogen-
esis [30,31], we are encouraged to examine whether the oxysterol-
induced Hh signaling and mitochondrial activity can converge at β-
catenin control during osteogenic induction. As shown in Fig. 6A,Mitochondrial a
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signaling signiﬁcantly decreased oxysterol-induced increases in β-
catenin mRNA expression (Fig. 6B). Alternatively, inhibition of mito-
chondrial biogenesis by AZT resulted in decreased oxysterol-induced
β-catenin, suggesting that mitochondrial biogenesis regulates Wnt/β-
catenin signaling during oxysterol-induced osteogenic induction
(Fig. 6C). In order to validate that oxysterols stimulate β-catenin
translocation, cells were exposed to 1 μM SS. Subsequently, cytosol
and nuclear proteinswere isolated.Western blot analysis demonstrated
that oxysterols enhanced the expression of β-catenin in the cytosol and
nucleus, but that AZT suppressed oxysterol-induced expression of β-
catenin (Fig. 6D). Moreover, TCF/LEF/β-catenin transcriptional activity
was signiﬁcantly increased by SS treatment, but the increase in reporter
gene activitywas abolished by cyclopamine or AZT treatment indicating
that Hh signaling and mitochondrial biogenesis regulates the transcrip-
tional activity of Wnt/β-catenin signaling (Fig. 6E). We next wanted to
determine the effect of Wnt/β-catenin signaling on the regulation of
oxysterol-related osteogenic factors. To conﬁrm the efﬁcacy of β-
catenin-speciﬁc siRNA, cells were transfected with either β-catenin or
negative control. Knockdown of β-catenin by siRNA transfection
blocked the increase in COLIA and OPN protein levels by 1 μM SS
treatment; the negative control siRNA transfection did not affect protein
levels (Fig. 6F). Moreover, the pattern of ALP activity was consistent
with Western blot analysis of COLIA and OPN suggesting that canonical
Wnt/β-catenin signaling is involved in oxysterol-induced ESC
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The present study demonstrated that speciﬁc oxysterols intensify
ESC osteogenic differentiation. Upon differentiation, oxysterols signiﬁ-
cantly increased markers of mitochondrial activity, while coupling
regulation of Hh/Gli and Wnt/β-catenin signaling. When we tried to
compare the osteoinductive effect between oxysterols and BMP2
(bonemorphogenetic protein 2), we found the differential actionmech-
anism of these agents to control osteogenic speciﬁcation of ESCs (Sup-
plemental Data 3). Even though BMP2 increased the ESC osteogenesis,
this factor showed a lesser extent of mitochondrial mass and mtDNA
copy number referred to as mitochondria biogenesis than oxysterols.
Moreover, BMP2 seems not to be involved in canonical Hh/Gli or Wnt/
β-catenin signaling in osteogenic differentiation of ESCs. Thus, these
ﬁndings provide experimental evidence that oxysterol-induced osteo-
genic differentiation of ESCs is regulated by a novel set of signal trans-
duction pathways. Recent studies have reported that oxysterols
represent naturally occurring regulatory molecules with important bio-
logical actions and play a prominent role in cell differentiation processes
[38,39]. In particular, oxysterols are identiﬁed as potential agents that
lead in vitro osteogenic differentiation and in vivo bone formation [11,
40,41]. In mesenchymal stem cell (MSC) models, speciﬁc oxysterol
combinations exert osteoinductive effects by activating critical signaling
pathways [10,12,42]. Consistentwith this, we observed that the individ-
ual 20S or 22S also has an osteoinductive effect on ESCs but combination
of oxysterols (SS) much more increased the ALP activity and [Ca2+]i
than single treatment after 7 or 14 days of exposure (Supplemental
Data 4). This phenomenon can be supported by previous study showing
that individual oxysterols fail to induce substantial mineralization and
osteogenic marker gene expression even after 14 days of treatment, de-
spite their osteogenic potency. However, oxysterol combination signiﬁ-
cantly stimulated the osteogenic differentiation of MSCs [43]. Even
though further experiments are needed to investigate the speciﬁc
mechanism how individual oxysterols reciprocally enhance the osteo-
genic activity, based on previous and our ﬁndings, we suggest that
oxysterols act as important modulators of stem cell differentiation into
osteogenic lineage.
Mitochondria are the main source of ATP and act as a center for
connecting extrinsic and intrinsic signals to direct cell growth, prolifer-
ation, and the differentiation process [44,45]. Increasing evidence
supports the notion that mitochondria participate in regulating stem
cell fate [19,46]. In this study, we provide clear evidence to suggest
that oxysterols increase mitochondrial content and biogenesis during
ESC osteogenic differentiation using various methods for measuring
mitochondrial activity. We detected 1) augmented ATP and ROS pro-
duction; 2) markers of mitochondrial biogenesis, including membrane
potential, mitochondrial mass, mRNA expression levels of PGC-1α and
PGC-1β, and mtDNA copy number; and 3) increased protein levels of
respiratory enzyme complexes during osteogenic differentiation.
Consistent with our ﬁndings, the connection between mitochondrial
activity and lineage differentiation has been observed during spontane-
ous differentiation of ESCs [19,47]. Another study using confocal
microscopy also revealed high mitochondrial membrane potential in
ESC-derived cardiomyocytes compared with undifferentiated ESCs,
indicating increased mitochondrial function concomitant with ESC
differentiation [48]. While many studies demonstrate higher mitochon-
drial action during stem cell differentiation into various types, others
have demonstrated that mitochondrial metabolism in human ESCs (by
measuring expression levels of PGC-1α and PGC-1β) is much higher
than in ESC-derived neural stem cells [49]. The reason for this
discrepancy is not clear. However, we suggest that mitochondria act in
important signaling pathways to regulate self-renewal and differentia-
tion of ESCs.
In accordance with previous study showing the regulatory effect of
oxysterols on Hh pathway [12], upregulation of canonical Hh/Gli1
signaling occurred during the oxysterol-induced ESC osteogenesis. Hhsignaling is well known as a main regulator of osteoblast differentiation
during skeletal development [50]. Interestingly, this study found the Hh
pathway can mediate the oxysterol-induced mitochondrial biogenesis
and respiratory function during the osteogenesis. Earlier study also
demonstrated the activated Hh signaling in hepatic stellate cells
(HSCs) induces glycolysis and increase of mitochondrial metabolism
during the transdifferentiation of HSCs into myoﬁbroblasts [51].
Since Hh pathway is well known to have the mitogenic functions
during development [52], we consider higher levels of respiratory
complexes (encoded by both nuclear and mitochondrial DNA with
the exception of complex II entirely encoded by the nucleus [53])
may be due to higher Hh signaling activation by oxysterols. Thus, it
can be encouraged that activation of Hh signaling is a putative criti-
cal process in enhancing mitochondrial respiratory function denoted
by the increased levels of respiratory enzyme complexes and ATP
content during the oxysterol-induced osteogenic differentiation of
ESCs.
Moreover, interactions betweenHhsignaling and other key differen-
tiation mechanism, such as Wnt, have been well documented [54]. In
the present study, oxysterols stimulate Wnt signaling pathways,
which inhibited by Smo inhibitor or Gli1 siRNA, suggesting that these
pathways collaborate to promote the ESC osteogenesis in response to
oxysterols. Wnt signaling is classiﬁed as canonical and non-canonical,
referred to as β-catenin dependent and independent signaling, respec-
tively [55]. The role of Wnt signaling in osteogenic regulation in a
variety of experimental models is likely complex. We show that canon-
ical Wnt/β-catenin signaling is activated by oxysterols during ESC
osteogenesis. In contrast, a previous study showed that treatment
with oxysterols increases osteogenic differentiation of marrow stromal
cells mediated through a non-canonical Wnt signaling-related mecha-
nism [42]. Despite these differences, both canonical and non-canonical
Wnt pathways may play a critical role in osteoinductive activity of
oxysterols. Interestingly, we also observed that inhibition of mitochon-
drial biogenesis, using AZT, occurs with down-regulated expression of
oxysterol-induced β-catenin. A number of studies report the critical
role of mitochondrial signaling pathways in ESCs; however, a detailed
mechanism and the biological importance to ESC differentiation has
not yet been elucidated. One previous study suggested that mitochon-
drial biogenesis increases β-catenin activity contributing to Wnt-
mediated osteoblastic differentiation of mesenchymal cells [45]. Based
on these results, we suggest that mitochondrial biogenesis may act as
an upstream regulator of Wnt/β-catenin signaling. Although this is a
new observation in ESCs, our ﬁndings suggest that oxysterol-induced
mitochondrial biogenesis interacts with Wnt/β-catenin signaling by
regulating the amount of β-catenin and its translocation into the nucle-
us, leading to cooperative activation of osteogenic differentiation in
ESCs. Thus, oxysterol-induced ESC osteogenic differentiation is
controlled by mitochondrial activity, which is linked to canonical Wnt
signaling.
In conclusion, we demonstrate that oxysterols stimulate osteo-
genic differentiation of ESCs by increasing mitochondrial activity
that is triggered through canonical Hh-regulated signaling
network, as well as its downstream target, Wnt/β-catenin signal-
ing (Fig. 7). Finally, these results in addition to enhancing stem
cell differentiation, aid in the identiﬁcation of osteogenic signaling
networks that could help improve the efﬁcacy of regenerative
therapies.
Supplementary data to this article can be found online at http://dx.
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